TY - JOUR
T1 - Preparation of porous PCL-PEG-PCL scaffolds using supercritical carbon dioxide
AU - Hadizadeh, Farzin
AU - Khodaverdi, Elham
AU - Oroojalian, Fatemeh
AU - Rahmanian-Devin, Pouria
AU - Hashemi, S. Hassan M.
AU - Omidkhah, Negar
AU - Asare-Addo, Kofi
AU - Nokhodchi, Ali
AU - Kamali, Hossein
N1 - Publisher Copyright:
© 2022 The Authors
PY - 2023/1/25
Y1 - 2023/1/25
N2 - In this study, the Supercritical Carbon Dioxide (scCO2) gas foaming procedure was used in the preparation of scaffolds containing the model drug dexamethasone (DXMT). The method used did not include an organic solvent thus making it a safe method. The ring-opening polymerization of PCL-PEG-PCL (PCEC) triblock was conducted using an organocatalyst [1,8 diazabicyclo [5.4.0] undec-7-ene (DBU)]. After mixing 5.0 g of DXMT with 50.0 g of PCEC, hydraulic pressure was applied to compress the mixed powder into disc-like tablets. The tablet-like scaffold of the triblock containing DXMT was inserted into a scCO2 gas-foaming device. The peak porosity percentage of the synthesized triblock was found to be 55.58 %. Pressure, temperature, soaking time and the time required to depressurize were recorded as 198 bar, 50 °C, 2.0 h, and 28 min respectively. After treatment with scCO2, the scaffolds experienced an almost full release of DXMT in vitro after 30 days (83.74±1.54 % vs. 52.24±2.03 % before scCO2 treatment). In conclusion, the results proved that the scCO2 gas foaming procedure could be employed for constructing modifiable PCEC scaffolds with plausible porosity and structural and morphological features which can manipulate drug release.
AB - In this study, the Supercritical Carbon Dioxide (scCO2) gas foaming procedure was used in the preparation of scaffolds containing the model drug dexamethasone (DXMT). The method used did not include an organic solvent thus making it a safe method. The ring-opening polymerization of PCL-PEG-PCL (PCEC) triblock was conducted using an organocatalyst [1,8 diazabicyclo [5.4.0] undec-7-ene (DBU)]. After mixing 5.0 g of DXMT with 50.0 g of PCEC, hydraulic pressure was applied to compress the mixed powder into disc-like tablets. The tablet-like scaffold of the triblock containing DXMT was inserted into a scCO2 gas-foaming device. The peak porosity percentage of the synthesized triblock was found to be 55.58 %. Pressure, temperature, soaking time and the time required to depressurize were recorded as 198 bar, 50 °C, 2.0 h, and 28 min respectively. After treatment with scCO2, the scaffolds experienced an almost full release of DXMT in vitro after 30 days (83.74±1.54 % vs. 52.24±2.03 % before scCO2 treatment). In conclusion, the results proved that the scCO2 gas foaming procedure could be employed for constructing modifiable PCEC scaffolds with plausible porosity and structural and morphological features which can manipulate drug release.
KW - Supercritical CO2 gas foaming
KW - Organocatalyst
KW - PCL-PEG-PCL
KW - Scaffold
KW - Supercritical CO gas foaming
UR - http://www.scopus.com/inward/record.url?scp=85145265970&partnerID=8YFLogxK
U2 - 10.1016/j.ijpharm.2022.122507
DO - 10.1016/j.ijpharm.2022.122507
M3 - Article
VL - 631
JO - International Journal of Pharmaceutics
JF - International Journal of Pharmaceutics
SN - 0378-5173
M1 - 122507
ER -